1 active not recruiting, 1 recruiting. 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Lu-177: new trials by email Literature Review of Lu-177 trials Research Report on Lu-177
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function Lu-177, SPECT - Lu-177 PSMA | Phase 4 | Recruiting | M.D. Anderson Cancer Center | 25 | 2026-03-30 | 2026-08-04 |
| Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors Cabozantinib, Lu-177 - Neuroendocrine Tumors | Phase 1 | Active not recruiting | Providence Health & Services | 6 | 2022-12-28 | 2026-04-13 |
M.D. Anderson Cancer Center (1) · Providence Health & Services (1)
United States (2)
Guofan Xu, MD (1) · Hagen Kennecke, MD (1)